Zenas BioPharma (ZBIO) Research & Development (2023 - 2026)

Zenas BioPharma's Research & Development history runs 4 years deep, the most recent figure standing at $60.4 million for Q1 2026.

• In Q1 2026, Research & Development rose 73.1% year-over-year to $60.4 million; the TTM figure through Mar 2026 stood at $193.6 million (up 27.86% YoY), while the FY2025 annual figure was $168.1 million, up 20.79% from the prior year.
• Research & Development was $60.4 million for Q1 2026 at Zenas BioPharma, up from $55.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $60.4 million in Q1 2026 to a low of $9.4 million in Q3 2023.
• Historically, Research & Development has averaged $36.1 million across 4 years, with a median of $34.4 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Research & Development surged 258.53% in 2024, then increased 2.6% in 2025.
• A 4-year view of Research & Development shows it stood at $20.4 million in 2023, then soared by 140.75% to $49.2 million in 2024, then increased by 13.35% to $55.7 million in 2025, then rose by 8.47% to $60.4 million in 2026.
• The last three Research & Development figures came in at $60.4 million (Q1 2026), $55.7 million (Q4 2025), and $34.4 million (Q3 2025), per Business Quant data.